KFDA and Industry meeting for bio equivalency test fraud issue.

Published: 2006-07-19 07:00:00

Updated: 2006-07-19 07:00:00

The KFDA and the pharmaceutical industry group have met together to discuss the issue of the bio equivalency test fraud at the 2nd floor of KPMA auditorium at 3 p.m. on July 19 in presence of the KFDA Drug Division head Moon Byeong-woo and Mr. Kim Hyeong-joong, the team leader of Drug Safety Poli...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK